Q3 2021 Holdings
Filed 2021-11-15 | 153 holdings | $827.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Align Technology Inc(ALGN) | COM | 016255101 | $133.1M | 200,000 | 16.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $118.0M | 2,556,179 | 14.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $95.1M | 315,000 | 11.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $68.5M | 3,803,232 | 8.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $63.8M | 400,000 | 7.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $58.7M | 311,000 | 7.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $47.5M | 577,500 | 5.7% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $45.3M | 710,000 | 5.5% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $26.3M | 750,307 | 3.2% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $24.3M | 1,075,912 | 2.9% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $23.5M | 1,579,191 | 2.8% |
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $22.5M | 764,701 | 2.7% |
| Conmed Corp(CNMD) | COM | 207410101 | $21.3M | 162,500 | 2.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $19.6M | 253,500 | 2.4% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $17.8M | 900,000 | 2.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $14.0M | 1,165,582 | 1.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $13.6M | 613,269 | 1.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $11.3M | 2,189,788 | 1.4% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $185.4K | 7,075,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $133.1K | 342,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $124.4K | 437,566 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $119.3K | 120,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $113.6K | 1,077,750 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $111.9K | 180,000 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $109.2K | 450,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $100.8K | 1,051,500 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $94.3K | 455,000 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $93.8K | 240,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $90.6K | 2,445,155 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $87.4K | 849,659 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $76.9K | 702,000 | 0.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $75.2K | 527,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $74.1K | 2,605,829 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $74.0K | 635,700 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $72.3K | 801,109 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $65.9K | 582,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $62.5K | 353,514 | 0.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $59.8K | 970,000 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $58.1K | 1,875,000 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $56.0K | 1,000,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $54.4K | 570,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $50.6K | 710,430 | 0.0% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $49.0K | 130,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $47.9K | 391,917 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $47.2K | 1,600,589 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $45.3K | 220,000 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $45.3K | 962,826 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $43.1K | 732,927 | 0.0% |
| Health Catalyst Inc(HCAT) | COM | 42225T107 | $42.5K | 850,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $42.5K | 250,000 | 0.0% |